CD4 and neoplasm: Upon examination of the CD3+ population, a significant enrichment of CD4+ and CD8+ T-cells within the tumour compartment at D7 was observed (Figure 7H, S5E) in mice that had received VSVΔ51+T-DM1, compared to those that received monotherapies or PBS control.